Tarbox Family Office, Inc. Moderna, Inc. Transaction History

Tarbox Family Office, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$117.13 - $176.59 $12,650 - $19,071	-108 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$126.46 - $235.05 $8,219 - $15,278	65 Added 151.16%	108 $19,000
Q4 2021 Jan 06, 2022	SELL	$225.82 - $368.51 $27,324 - $44,589	-121 Reduced 73.78%	43 $11,000
Q3 2021 Oct 12, 2021	BUY	$221.9 - $484.47 $29,068 - $63,465	131 Added 396.97%	164 $63,000
Q2 2021 Jul 16, 2021	BUY	$129.91 - $234.98 $1,818 - $3,289	14 Added 73.68%	33 $8,000
Q1 2021 Apr 27, 2021	SELL	$109.18 - $185.98 $5,459 - $9,299	-50 Reduced 72.46%	19 $2,000
Q4 2020 Jan 27, 2021	BUY	$65.74 - $169.86 $3,286 - $8,493	50 Added 263.16%	69 $7,000
Q1 2020 Apr 30, 2020	BUY	$17.78 - $31.58 $337 - $600	19 New	19 $1,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.